Startups

Founded in 2016 with a broad remit of financial data aggregation and analysis, MioTech has turned its focus to ESG, a new sweet spot for investors. In doing so, its client base has doubled in a year and its financial backers are firmly committed.

After announcing a $100 million Series B+ funding, the biotech company’s CEO tells FinanceAsia it is now in full IPO preparation mode with Hong Kong as its preferred destination. However, a dual listing is not out of the question.

As global investment into healthcare dips, some pre-IPO investors hold high hopes one Chinese pharma company can take on AstraZeneca and win big in the China respiratory drug market.

The Moscow-based conglomerate is looking to launch its second Asia fund in 2020, to capture the growth in the region’s burgeoning middle class. It is also expanding in Southeast Asia.

The trade war with the US has put Japanese investors off China. Southeast Asia remains top of their list in the hunt for better returns.

The $70 million Series D funding for CarDekho, is just the most recent example of Chinese funds using their expertise at home to make similar investment calls overseas.

FinanceAsia is showcasing the entrepreneurs who are leading the wave of technological disruption across the region. Here we look at Thailand.

Funding for Taiwan’s Appier hits $162 million as the AI software company looks at workforce and geographic expansion.

FinanceAsia is showcasing the entrepreneurs who are leading the wave of technological disruption across the region. Here we look at Taiwan.